Literature DB >> 29987569

Trans-perineal minimally invasive surgery during laparoscopic abdominoperineal resection for low rectal cancer.

Daiki Yasukawa1, Tomohide Hori2, Yoshio Kadokawa3, Shigeru Kato3, Yuki Aisu3, Suguru Hasegawa4.   

Abstract

BACKGROUND: Laparoscopic abdominoperineal resection (APR) for low rectal cancer (LRC) is performed worldwide. However, APR involves technical difficulties and often causes intractable perineal complications. Therefore, a novel and secure technique during APR is required to overcome these critical issues. Although the usefulness of the endoscopic trans-anal approach has been documented, no series of the endoscopic trans-perineal approach during laparoscopic APR for LRC has been reported.
METHODS: Trans-perineal minimally invasive surgery (TpMIS) has been used during laparoscopic APR in our institution since April 2014. TpMIS is defined as an endoscopic trans-perineal approach using a single-port device and laparoscopic instruments. In this study, we retrospectively evaluated 50 consecutive patients with LRC who underwent laparoscopic APR at our institution from February 2011 to June 2017 and compared the outcomes of the patients who underwent TpMIS [trans-perineal APR (TpAPR) group, n = 21] versus the conventional trans-perineal approach (conventional group, n = 29). We investigated our experiences with TpMIS in detail and evaluated the safety and utility of TpMIS for patients with LRC. Moreover, major features and difficulties of TpMIS were examined from a surgical viewpoint.
RESULTS: Intraoperative blood loss (median (range) 55 (10-600) vs. 120 (20-1650) ml) and severe perineal wound infection (Clavien-Dindo grade 3, 0 vs. 5 cases) were significantly lower in the TpAPR than conventional group. TpMIS led to a shortened hospital stay (median (range), 14 (10-74) vs. 23 (10-84) days), and neither mortality nor conversion to open surgery occurred in the TpAPR group.
CONCLUSIONS: Magnified visualization via endoscopy provided more accurate dissection and less blood loss during surgery. Minimal skin incisions enabled a reduction in postoperative perineal complications, and consequently shortened the hospital stay. TpMIS during laparoscopic APR is safe and beneficial for patients with LRC.

Entities:  

Keywords:  Abdominoperineal resection; Endoscopic trans-perineal approach; Laparoscopy; Minimally invasive surgery; Perineal complication; Rectal cancer

Mesh:

Year:  2018        PMID: 29987569     DOI: 10.1007/s00464-018-6316-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  31 in total

1.  Prospective controlled study of the safety and oncological outcomes of ELAPE procure with definitive anatomic landmarks versus conventional APE for lower rectal cancer.

Authors:  Z Shen; Y Ye; X Zhang; Q Xie; M Yin; X Yang; K Jiang; B Liang; S Wang
Journal:  Eur J Surg Oncol       Date:  2015-01-30       Impact factor: 4.424

2.  Neoadjuvant treatment for locally advanced rectal cancer: a systematic review.

Authors:  Keisuke Uehara; Masato Nagino
Journal:  Surg Today       Date:  2015-07-14       Impact factor: 2.549

Review 3.  Evolution of Surgical Treatment for Rectal Cancer: a Review.

Authors:  Sanjeev Dayal; Nick Battersby; Tom Cecil
Journal:  J Gastrointest Surg       Date:  2017-04-25       Impact factor: 3.452

Review 4.  Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management.

Authors:  Aaron J Franke; Hiral Parekh; Jason S Starr; Sanda A Tan; Atif Iqbal; Thomas J George
Journal:  Clin Colorectal Cancer       Date:  2017-06-27       Impact factor: 4.481

5.  The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After Esophagectomy.

Authors:  Akio Nakagawa; Tetsu Nakamura; Taro Oshikiri; Hiroshi Hasegawa; Masashi Yamamoto; Shingo Kanaji; Yoshiko Matsuda; Kimihiro Yamashita; Takeru Matsuda; Yasuo Sumi; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Ann Surg Oncol       Date:  2017-10-06       Impact factor: 5.344

6.  Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience.

Authors:  M W Onaitis; R B Noone; M Hartwig; H Hurwitz; M Morse; P Jowell; K McGrath; C Lee; M S Anscher; B Clary; C Mantyh; T N Pappas; K Ludwig; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2001-06       Impact factor: 12.969

Review 7.  A Systematic Review to Assess Resection Margin Status After Abdominoperineal Excision and Pelvic Exenteration for Rectal Cancer.

Authors:  Constantinos Simillis; Daniel L H Baird; Christos Kontovounisios; Nikhil Pawa; Gina Brown; Shahnawaz Rasheed; Paris P Tekkis
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

8.  Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.

Authors:  SooYoon Sung; Sung Hwan Kim; Joo Hwan Lee; Taek Keun Nam; Songmi Jeong; Hong Seok Jang; Jin Ho Song; Jeong Won Lee; Jung Min Bae; Jong Hoon Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-14       Impact factor: 7.038

Review 9.  An update on the multimodality of localized rectal cancer.

Authors:  Mehmet Artac; Levent Korkmaz; Bassel El-Rayes; Philip A Philip
Journal:  Crit Rev Oncol Hematol       Date:  2016-10-26       Impact factor: 6.312

10.  Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis.

Authors:  Shi-Xin Liu; Zhi-Rui Zhou; Ling-Xiao Chen; Yong-Jing Yang; Zhi-De Hu; Tian-Song Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2015
View more
  2 in total

1.  Transperineal total mesorectal excision for rectal cancer on the residual rectum after multiple abdominal surgeries in a patient with Crohn's disease: a case report.

Authors:  Shin Emoto; Shigenori Homma; Tadashi Yoshida; Nobuki Ichikawa; Yoichi Miyaoka; Hiroki Matsui; Ryo Takahashi; Keita Ishido; Takuya Otsuka; Tomoko Mitsuhashi; Takehiko Katsurada; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2021-05-13

2.  Transperineal minimally invasive APE: preliminary outcomes in a multicenter cohort.

Authors:  S E van Oostendorp; S X Roodbeen; C C Chen; A Caycedo-Marulanda; H M Joshi; P J Tanis; C Cunningham; J B Tuynman; R Hompes
Journal:  Tech Coloproctol       Date:  2020-06-16       Impact factor: 3.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.